A 6-month course of intravenous ganciclovir or valganciclovir is recommended for treatment of patients with moderate to severe symptomatic congenital CMV disease. Hearing status improvement has been reported in those that received treatment within the first month of...
Keywords: cytomegalovirus (CMV); donor lymphocyte infusions (DLIs); graft versus host disease (GvHD); naive T-cell depletion 1. Introduction Hematopoietic stem cell transplantation (HSCT) is a curative therapeutic approach for several hematologic and non-hematologic disorders. Infectious complications due...